881TiP A multi-centre, open-label phase II trial of the combination of VB10.16 and atezolizumab in patients with advanced or recurrent, non-resectable HPV16 positive cervical cance... von Hillemanns, P., Baurain, J-F., Blecharz, P., Lindemann, K., Nicolaisen, B., Schetne, K., Fredriksen, A.B., Torhaug, S.

Volltext

T Cells from Multiple Sclerosis Patients Recognize Multiple Epitopes on Self-IgG von Hestvik, A.L.K, Vartdal, F, Fredriksen, A.B, Thompson, K.M, Kvale, E.O, Skorstad, G, Bogen, B, Holmoy, T

Volltext